Brind.

Adisseo Reports Strong Q3 Performance Amid Shanghai Stock Exchange Listing

1 report, 1 independent Updated Tue 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Adisseo launched a global campaign in Shanghai to celebrate its 20-year partnership with Sinochem. During this period, the company reported robust Q3 2026 financial results, including CNY 5.57 billion in revenue, a 76% year-over-year increase in EBITDA, and CNY 762 million in net profit, which was up 204% year-over-year. The company is noted as the first international company listed on the Shanghai Stock Exchange.

From poultrymed.com

Why it matters

Some supportBrind's analysis of the reports

The financial highlights show significant growth in Adisseo's operations, driven by strong methionine sales and improved specialty margins. The company's status as a global leader in animal nutrition, supported by a cumulative investment of €3 billion, underscores its market position. Adisseo is a subsidiary of China National Bluestar.

From poultrymed.com

Who's involved

  • AdisseoGlobal animal nutrition company that reported Q3 financials and launched a campaign in Shanghai.
  • China National BluestarParent company of Adisseo, an industrial chemicals company from China.
  • ShanghaiLocation where Adisseo conducted its global campaign.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped